HOOKIPA Pharma (HOOK)
(Delayed Data from NSDQ)
$0.89 USD
+0.09 (10.82%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.89 0.00 (-0.37%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum B VGM
Cash flow Statements
Fiscal Year End for HOOKIPA Pharma Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -81.58 | -64.92 | -75.67 | -44.08 | -43.04 |
Depreciation/Amortization & Depletion | 3.55 | 3.60 | 4.64 | 4.15 | 1.44 |
Net Change from Assets/Liabilities | 5.33 | 36.11 | -3.86 | -8.12 | -7.38 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 15.18 | 5.20 | 8.87 | 8.71 | 7.24 |
Net Cash From Operating Activities | -57.52 | -20.00 | -66.02 | -39.34 | -41.73 |
Property & Equipment | -4.16 | -5.02 | -12.58 | -2.37 | -2.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -4.16 | -5.02 | -12.58 | -2.37 | -2.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 67.57 | 75.32 | 0.20 | 75.06 | 112.03 |
Issuance (Repayment) of Debt | -1.75 | -2.85 | -0.44 | -1.42 | -2.28 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.15 | -0.20 | 0.00 | -0.22 | 0.00 |
Net Cash from Financing Activities | 65.67 | 72.27 | -0.24 | 73.42 | 109.75 |
Effect of Exchange Rate Changes | 0.09 | -0.73 | 2.57 | -2.11 | -1.03 |
Net Change In Cash & Equivalents | 4.08 | 46.53 | -76.27 | 29.60 | 65.00 |
Cash at Beginning of Period | 113.44 | 66.91 | 143.18 | 113.58 | 48.58 |
Cash at End of Period | 117.52 | 113.44 | 66.91 | 143.18 | 113.58 |
Diluted Net EPS | -0.86 | -0.99 | -2.30 | -1.69 | -2.41 |
Fiscal Year End for HOOKIPA Pharma Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -81.58 | -56.76 | -37.70 | -19.68 |
Depreciation/Amortization & Depletion | NA | 3.55 | 2.27 | 1.79 | 0.92 |
Net Change from Assets/Liabilities | NA | 5.33 | 6.26 | 12.37 | 15.25 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 15.18 | 1.93 | 1.36 | 0.66 |
Net Cash From Operating Activities | NA | -57.52 | -46.30 | -22.18 | -2.85 |
Property & Equipment | NA | -4.16 | -3.74 | -0.72 | -0.27 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -4.16 | -3.74 | -0.72 | -0.27 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 67.57 | 46.32 | 46.98 | 0.00 |
Issuance (Repayment) of Debt | NA | -1.75 | -1.75 | -1.75 | -0.60 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -0.15 | -0.15 | -0.15 | -0.14 |
Net Cash from Financing Activities | NA | 65.67 | 44.42 | 45.08 | -0.74 |
Effect of Exchange Rate Changes | NA | 0.09 | 0.27 | 0.39 | 0.43 |
Net Change In Cash & Equivalents | NA | 4.08 | -5.35 | 22.57 | -3.42 |
Cash at Beginning of Period | NA | 113.44 | 113.44 | 113.44 | 113.44 |
Cash at End of Period | NA | 117.52 | 108.10 | 136.01 | 110.02 |
Diluted Net EPS | NA | -0.20 | -0.17 | -0.22 | -0.27 |